GSK Epilepsy, Bipolar Drug Linked To Meningitis

Law360, New York (August 13, 2010, 11:52 AM EDT) -- The U.S. Food and Drug Administration is revising the label on GlaxoSmithKline PLC epilepsy and bipolar disorder drug Lamictal to warn consumers that it can cause viral meningitis, which can in rare cases lead to brain infections.

The agency announced Thursday that Lamictal can cause aseptic meningitis, an inflammation of membranes that surround the spinal cord and brain that is less severe than bacterial meningitis but can require hospitalization.

According to the FDA, GSK is working with the agency to update the warnings and precautions section...
To view the full article, register now.